Schellenberg Wittmer advised Axpo Solutions on the sale of its 5% stake in Trans Adriatic Pipeline (TAP) to TAP’s shareholders Enagás and Fluxys for EUR 210 million. Fluxys acquires 1% and Enagás 4%. The transaction is
Tags :sx1
Kemaro, the Switzerland based developer of the K900 autonmous cleaning robot for industrial use, has secured additional capital in a Series A financing round to continue its worldwide expansion. Obayashi Corporation, one of the five
Benjamin Gottlieb has been appointed partner of Schellenberg Wittmer as of 1 January 2023. He has extensive experience in arbitration and is an expert in the United Nations Convention on Contracts for the International Sale of Goods (
Wenger Vieli kicks off 2023 with Daniel Oehri (pictured left) and Patric Eggler (pictured right) as new partners in corporate and tax respectively. Daniel Oehri’s practice focuses on general corporate and contract law, restructuring and
Niklaus Kunz has joined Wenger Vieli as senior associate from Bihrer Rechtsanwälte. He is mainly active in the areas of banking and financial market law, capital market law and compliance. He is based in
As we have informed here NLS Pharmaceutics, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, announced that it has
Scope Law strengthens its legal team with the addition of a new partner. Denise Läubli will join the law firm as partner as of January 1, 2023. Läubli’s practice focuses on real estate, construction,
Anna Tomaschek has joined Advestra from Wenger Vieli on 1 December 2022. She is active in the areas of m&a, capital markets and financing transactions. Tomaschek also advises companies on corporate and stock exchange law
BianchiSchwald has promoted Charles-Louis Notter to Managing Associate within the litigation practice group as of January 1st, 2023. Notter has joined BianchiSchwald in Geneva in 2019 and specializes in civil litigation, with a focus on asset recovery
Niederer Kraft Frey has advised Invision, a leading equity investment company, on the acquisition of a majority stake in Careanesth. The transaction is subject to merger control clearance. Since its founding in 1999, Careanesth has
